Skip to main content
Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc. — Investor Relations & Filings

Ticker · TNGX ISIN · US87583X1090 US Professional, scientific and technical activities
Filings indexed 355 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country US United States of America
Listing US TNGX

About Tango Therapeutics, Inc.

https://www.tangotx.com/

Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing a new generation of precision oncology medicines. The company's approach is centered on the principle of synthetic lethality, a genetic strategy to target cancer vulnerabilities. By utilizing its proprietary drug discovery platform, which integrates CRISPR technology, Tango identifies novel drug targets and develops therapies for genetically defined patient populations with unmet medical needs. The company's pipeline is designed to deliver transformative medicines that take direct aim at specific tumors, with the goal of expanding the reach of genetically targeted cancer therapies.

Recent filings

Filing Released Lang Actions
8-K - Tango Therapeutics, Inc. (0001819133) (Filer)
Regulatory Filings
2026-05-13 English
8-K - Tango Therapeutics, Inc. (0001819133) (Filer)
Regulatory Filings
2026-05-08 English
ARS - Tango Therapeutics, Inc. (0001819133) (Filer)
Annual Report
2026-04-17 English
DEF 14A - Tango Therapeutics, Inc. (0001819133) (Filer)
Proxy Solicitation & Information Statement
2026-04-17 English
8-K - Tango Therapeutics, Inc. (0001819133) (Filer)
Regulatory Filings
2026-04-15 English
4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
Director's Dealing
2026-03-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.